Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California
Venice Servellita, Mary Kate Morris, Alicia Sotomayor-González, Amelia S. Gliwa, Erika Elizabeth Rodríguez‐Torres, Noah Brazer, Alicia Y. Zhou, Katherine Hernandez, Madeline Sankaran, Baolin Wang, Daniel Wong, Candace Wang, Yueyuan Zhang, Kevin Reyes, Dustin R. Glasner, Xianding Deng, Jessica Streithorst, Steve Miller, Edwin C. Frias, Mary A. Rodgers, Gavin Cloherty, John Hackett, Carl V. Hanson, Debra A. Wadford, Susan Philip, Scott Topper, Darpun Sachdev, Charles Y. Chiu
Topics & Concepts
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)BayVirologyCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakAntibodySars virusMedicineBiologyGeographyImmunologyOutbreakInfectious disease (medical specialty)ArchaeologyDiseasePathologySARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingCOVID-19 Clinical Research Studies